儿科重症监护镇静镇痛潜在的神经发育影响:重复苯二氮䓬和阿片暴露改变幼年大鼠胶质和突触蛋白表达
该研究在出生后18-22天Long-Evans大鼠中每日两次注射吗啡+咪达唑仑,23-24天逐渐减量,对照包括生理盐水、吗啡或咪达唑仑。吗啡+咪达唑仑组和吗啡组体重增长少于生理盐水或咪达唑仑组(p≤0.01)。与生理盐水相比,吗啡+咪达唑仑组drebrin显著升高(p=0.01),胶质纤维酸性蛋白数值下降但未达统计学显著。作者结论认为该新型啮齿类模型显示重复吗啡和咪达唑仑给药影响突触、星形胶质、小胶质和髓鞘蛋白,需进一步研究,可能对需要镇静镇痛的危重患儿有提示意义。
要点
- 在出生后18-22天幼年大鼠中,每日两次吗啡+咪达唑仑、23-24天减量,吗啡+咪达唑仑组和吗啡组体重增长少于生理盐水或咪达唑仑组(p≤0.01)。
- 与生理盐水相比,吗啡+咪达唑仑组drebrin水平显著升高(p=0.01),胶质纤维酸性蛋白数值下降但未达统计学显著。
- 吗啡组胶质纤维酸性蛋白较低,S100钙结合蛋白B和突触素较高。
- 咪达唑仑组S100钙结合蛋白B显著升高(p<0.001),17-18.5 kDa髓鞘碱性蛋白剪接异构体显著升高(p=0.01),突触素、离子钙结合衔接分子1和21.5 kDa髓鞘碱性蛋白数值升高,胶质纤维酸性蛋白数值下降。
- 作者结论认为这些发现需进一步研究,可能对需要镇静镇痛的危重患儿有提示意义。
适用人群与场景
- 雄性及雌性Long-Evans大鼠,出生后18-22天(相当于幼年期),23-24天减量。
处置流程与药物剂量
- 吗啡+咪达唑仑联合注射,每日两次,从出生后第18天至第22天,第23天和第24天逐渐减量;对照包括生理盐水、吗啡或咪达唑仑。
研究设计与关键结果
- 动物模型:雄性及雌性Long-Evans大鼠,出生后18-22天每日两次注射吗啡+咪达唑仑,23-24天减量;对照为生理盐水、吗啡或咪达唑仑。
- 吗啡+咪达唑仑组和吗啡组体重增长少于生理盐水或咪达唑仑组(p≤0.01)。
- 与生理盐水相比,吗啡+咪达唑仑组drebrin水平显著升高(p=0.01),胶质纤维酸性蛋白数值下降但未达统计学显著。
- 吗啡组胶质纤维酸性蛋白较低,S100钙结合蛋白B和突触素较高。
- 咪达唑仑组S100钙结合蛋白B显著升高(p<0.001),17-18.5 kDa髓鞘碱性蛋白剪接异构体显著升高(p=0.01),突触素、离子钙结合衔接分子1和21.5 kDa髓鞘碱性蛋白数值升高,胶质纤维酸性蛋白数值下降。
证据类型、等级与局限
- 证据类型:动物模型(基础科学实验室)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现需进一步研究,可能对需要镇静镇痛的危重患儿有提示意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Sedatives are suspected contributors to neurologic dysfunction in PICU patients, to whom they are administered during sensitive neurodevelopment. Relevant preclinical modeling has largely used comparatively brief anesthesia in infant age-approximate animals, with insufficient study of repetitive combined drug administration during childhood. We hypothesized that childhood neurodevelopment is selectively vulnerable to repeated treatment with benzodiazepine and opioid. We report a preclinical model of combined midazolam and morphine in early childhood age-approximate rats.
DESIGN: Animal model.
SETTING: Basic science laboratory.
SUBJECTS: Male and female Long-Evans rats.
INTERVENTIONS: Injections of morphine + midazolam were administered twice daily from postnatal days 18-22, tapering on postnatal days 23 and 24. Control groups included saline, morphine, or midazolam. To screen for acute neurodevelopmental effects, brain homogenates were analyzed by western blot for synaptophysin, drebrin, glial fibrillary acidic protein, S100 calcium-binding protein B, ionized calcium-binding adaptor molecule 1, and myelin basic proteins. Data analysis used Kruskal-Wallis with Dunn posttest, with a p value of less than 0.05 significance.
MEASUREMENTS AND MAIN RESULTS: Morphine + midazolam and morphine animals gained less weight than saline or midazolam (p ≤ 0.01). Compared with saline, morphine + midazolam expressed significantly higher drebrin levels (p = 0.01), with numerically but not statistically decreased glial fibrillary acidic protein. Similarly, morphine animals exhibited less glial fibrillary acidic protein and more S100 calcium-binding protein B and synaptophysin. Midazolam animals expressed significantly more S100 calcium-binding protein B (p < 0.001) and 17-18.5 kDa myelin basic protein splicing isoform (p = 0.01), with numerically increased synaptophysin, ionized calcium-binding adaptor molecule 1, and 21.5 kDa myelin basic protein, and decreased glial fibrillary acidic protein.
CONCLUSIONS: Analysis of brain tissue in this novel rodent model of repetitive morphine and midazolam administration showed effects on synaptic, astrocytic, microglial, and myelin proteins. These findings warrant further investigation because they may have implications for critically ill children requiring sedation and analgesia.
参考来源
- Iqbal O'Meara AM, Miller Ferguson N, Zven SE, et al. Potential Neurodevelopmental Effects of Pediatric Intensive Care Sedation and Analgesia: Repetitive Benzodiazepine and Opioid Exposure Alters Expression of Glial and Synaptic Proteins in Juvenile Rats. Crit Care Explor. 2020. PMID: 32426747. doi:10.1097/CCE.0000000000000105
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。